Andrius Varanavicius
Directeur/Membre du Conseil chez Takeda Pharma AG
Profil
Andrius Varanavicius is currently a Director at Takeda UK Ltd.
and Takeda Pharma AG.
He previously worked as a Director-Finance at Takeda Pharmaceuticals International AG.
In 2018, he became a Member-Supervisory Board at KN Energies AB, where he served until 2020.
Mr. Varanavicius obtained his undergraduate degree from Concordia International University in 2001.
Postes actifs de Andrius Varanavicius
| Sociétés | Poste | Début |
|---|---|---|
Takeda Pharma AG
 Takeda Pharma AG Pharmaceuticals: MajorHealth Technology Takeda Pharma AG engages in the distribution of pharmaceutical products. It offers vaccines and medicines for the treatment of diseases focused on oncology, gastroenterology, and central nervous system therapy. The company was founded on November 19, 1986 and is headquartered in Pfaeffikon, Switzerland. | Directeur/Membre du Conseil | - |
Takeda UK Ltd.
 Takeda UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda UK Ltd. is a company that manufactures and distributes pharmaceutical products. The company is based in Wooburn Green, UK. The British company was founded in 1997. Seyda Atadan Memis has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Anciens postes connus de Andrius Varanavicius
| Sociétés | Poste | Fin |
|---|---|---|
| AB KN ENERGIES | Directeur/Membre du Conseil | 31/07/2020 |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Directeur Financier/CFO | - |
Formation de Andrius Varanavicius
| Concordia International University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AB KN ENERGIES | Industrial Services |
| Entreprise privées | 3 |
|---|---|
Takeda Pharmaceuticals International AG
Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Health Technology |
Takeda Pharma AG
Takeda Pharma AG Pharmaceuticals: MajorHealth Technology Takeda Pharma AG engages in the distribution of pharmaceutical products. It offers vaccines and medicines for the treatment of diseases focused on oncology, gastroenterology, and central nervous system therapy. The company was founded on November 19, 1986 and is headquartered in Pfaeffikon, Switzerland. | Health Technology |
Takeda UK Ltd.
Takeda UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda UK Ltd. is a company that manufactures and distributes pharmaceutical products. The company is based in Wooburn Green, UK. The British company was founded in 1997. Seyda Atadan Memis has been the CEO of the company since 2022. | Health Technology |
